Adaptation of the endemic coronaviruses HCoV-OC43 and HCoV-229E to the human host.
antigenic drift
endemic coronavirus
molecular dating
molecular evolution
positive selection
receptor binding
Journal
Virus evolution
ISSN: 2057-1577
Titre abrégé: Virus Evol
Pays: England
ID NLM: 101664675
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
04
2021
revised:
18
06
2021
accepted:
23
06
2021
entrez:
16
9
2021
pubmed:
17
9
2021
medline:
17
9
2021
Statut:
epublish
Résumé
Four coronaviruses (HCoV-OC43, HCoV-HKU1, HCoV-NL63, and HCoV-229E) are endemic in human populations. All these viruses are seasonal and generate short-term immunity. Like the highly pathogenic coronaviruses, the endemic coronaviruses have zoonotic origins. Thus, understanding the evolutionary dynamics of these human viruses might provide insight into the future trajectories of SARS-CoV-2 evolution. Because the zoonotic sources of HCoV-OC43 and HCoV-229E are known, we applied a population genetics-phylogenetic approach to investigate which selective events accompanied the divergence of these viruses from the animal ones. Results indicated that positive selection drove the evolution of some accessory proteins, as well as of the membrane proteins. However, the spike proteins of both viruses and the hemagglutinin-esterase (HE) of HCoV-OC43 represented the major selection targets. Specifically, for both viruses, most positively selected sites map to the receptor-binding domains (RBDs) and are polymorphic. Molecular dating for the HCoV-229E spike protein indicated that RBD Classes I, II, III, and IV emerged 3-9 years apart. However, since the appearance of Class V (with much higher binding affinity), around 25 years ago, limited genetic diversity accumulated in the RBD. These different time intervals are not fully consistent with the hypothesis that HCoV-229E spike evolution was driven by antigenic drift. An alternative, not mutually exclusive possibility is that strains with higher affinity for the cellular receptor have out-competed strains with lower affinity. The evolution of the HCoV-OC43 spike protein was also suggested to undergo antigenic drift. However, we also found abundant signals of positive selection in HE. Whereas such signals might result from antigenic drift, as well, previous data showing co-evolution of the spike protein with HE suggest that optimization for human cell infection also drove the evolution of this virus. These data provide insight into the possible trajectories of SARS-CoV-2 evolution, especially in case the virus should become endemic.
Identifiants
pubmed: 34527284
doi: 10.1093/ve/veab061
pii: veab061
pmc: PMC8344746
doi:
Types de publication
Journal Article
Langues
eng
Pagination
veab061Informations de copyright
© The Author(s) 2021. Published by Oxford University Press.
Références
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
PLoS Genet. 2011 Dec;7(12):e1002395
pubmed: 22144911
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
Intervirology. 2018;61(1):30-35
pubmed: 30041172
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
Mol Ecol. 2011 Aug;20(15):3087-101
pubmed: 21740474
J Mol Evol. 1992 Feb;34(2):126-9
pubmed: 1556748
J Virol. 2005 Feb;79(3):1595-604
pubmed: 15650185
Elife. 2021 Jan 19;10:
pubmed: 33463525
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Nature. 2020 Jul;583(7815):286-289
pubmed: 32380510
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13757-62
pubmed: 11717435
Science. 2003 Jun 20;300(5627):1966-70
pubmed: 12766207
Methods Ecol Evol. 2016 Jan;7(1):80-89
pubmed: 27110344
Virology. 2018 Feb;515:134-149
pubmed: 29287230
J Infect Dis. 2021 Feb 13;223(3):409-415
pubmed: 32692346
mBio. 2014 Feb 18;5(1):
pubmed: 24549846
Science. 2021 Jan 8;371(6525):172-177
pubmed: 33172935
J Virol. 2005 Mar;79(5):3223-4; author reply 3224-5
pubmed: 15709046
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19970-4
pubmed: 19901337
Glycoconj J. 2006 Feb;23(1-2):59-72
pubmed: 16575523
Cell Host Microbe. 2021 Apr 14;29(4):522-528.e2
pubmed: 33789085
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25759-25770
pubmed: 32994342
J Virol. 2006 Nov;80(22):10909-18
pubmed: 16956938
Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9864-9
pubmed: 27528677
J Virol. 2020 Jun 1;94(12):
pubmed: 32238584
Cell Mol Immunol. 2020 Jun;17(6):621-630
pubmed: 32415260
Bioinformatics. 2000 Jun;16(6):562-3
pubmed: 10980155
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
Protein Cell. 2013 Dec;4(12):951-61
pubmed: 24318862
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
J Mol Biol. 1993 Dec 5;234(3):779-815
pubmed: 8254673
Cell. 2021 Apr 29;184(9):2384-2393.e12
pubmed: 33794143
Cell. 2021 Apr 29;184(9):2362-2371.e9
pubmed: 33735608
J Virol. 2012 Dec;86(23):12816-25
pubmed: 22993147
Nucleic Acids Res. 2003 Jul 1;31(13):3316-9
pubmed: 12824316
PLoS Pathog. 2021 Apr 8;17(4):e1009453
pubmed: 33831132
Infect Genet Evol. 2020 Oct;84:104384
pubmed: 32473976
Sci Rep. 2015 Sep 25;5:14480
pubmed: 26404138
Adv Virus Res. 2018;100:163-188
pubmed: 29551135
PLoS Pathog. 2020 Sep 3;16(9):e1008758
pubmed: 32881980
J Infect Dis. 2018 May 5;217(11):1728-1739
pubmed: 29741740
Science. 2021 Mar 12;371(6534):1152-1153
pubmed: 33514629
Nat Med. 2020 Nov;26(11):1691-1693
pubmed: 32929268
J Virol. 2017 Feb 14;91(5):
pubmed: 28077633
Syst Biol. 2011 Mar;60(2):150-60
pubmed: 21187451
N Engl J Med. 2003 May 15;348(20):1967-76
pubmed: 12690091
Nat Med. 2021 Apr;27(4):620-621
pubmed: 33558724
Cell Host Microbe. 2017 Mar 8;21(3):356-366
pubmed: 28279346
Nucleic Acids Res. 2003 Jul 1;31(13):3537-9
pubmed: 12824361
Int J Biol Sci. 2020 Mar 15;16(10):1686-1697
pubmed: 32226286
PLoS Comput Biol. 2014 Apr 10;10(4):e1003537
pubmed: 24722319
Virol J. 2016 Feb 25;13:33
pubmed: 26916286
Mol Biol Evol. 2018 Jan 1;35(1):247-251
pubmed: 29029186
Nucleic Acids Res. 2017 Jul 3;45(W1):W24-W29
pubmed: 28472356
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2681-2690
pubmed: 30679277
J Virol. 2006 Jul;80(14):7270-4
pubmed: 16809333
Nature. 2016 Mar 3;531(7592):114-117
pubmed: 26855426
PLoS Pathog. 2020 May 14;16(5):e1008421
pubmed: 32407364
Cell. 2021 Apr 29;184(9):2348-2361.e6
pubmed: 33730597
Emerg Infect Dis. 2021 May;27(5):1522-1524
pubmed: 33605869
Cell. 2020 Sep 3;182(5):1295-1310.e20
pubmed: 32841599
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
Bioinformatics. 2006 Jan 15;22(2):195-201
pubmed: 16301204
J Virol. 2015 Dec;89(23):11858-70
pubmed: 26378164
Bioinformatics. 1998;14(9):817-8
pubmed: 9918953
Elife. 2019 Oct 25;8:
pubmed: 31650956
Euro Surveill. 2021 Jan;26(1):
pubmed: 33413740
Mol Biol Evol. 2015 Jul;32(7):1895-906
pubmed: 25771196
PLoS One. 2009 Jul 02;4(7):e6130
pubmed: 19572016
Cell Mol Immunol. 2014 Mar;11(2):141-9
pubmed: 24509444
Methods Mol Biol. 2017;1525:433-460
pubmed: 27896731
J Gen Virol. 2013 Sep;94(Pt 9):2036-2049
pubmed: 23804565
Nat Commun. 2017 Nov 23;8(1):1735
pubmed: 29170370
Virus Evol. 2021 Mar 20;7(1):veab020
pubmed: 33768964
Emerg Infect Dis. 2009 Sep;15(9):1377-84
pubmed: 19788804
Mol Biol Evol. 1989 Sep;6(5):526-38
pubmed: 2677599
J Struct Funct Genomics. 2016 Dec;17(4):83-99
pubmed: 27522608
J Virol. 2015 Nov;89(22):11383-95
pubmed: 26339053
Nature. 2021 May;593(7857):130-135
pubmed: 33684923
Trends Microbiol. 2017 Jan;25(1):35-48
pubmed: 27743750
Emerg Infect Dis. 2020 Feb;26(2):191-198
pubmed: 31961300